PHGE AMEX
BiomX Inc.
1W: -27.7%
1M: +590.8%
3M: +99.5%
YTD: -50.0%
1Y: -88.9%
3Y: -98.6%
5Y: -99.8%
$1.85
Last traded 2026-09-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$3M
-62.1% ▼
Operating Income
-$33M
+15.7% ▲
Net Income
-$36M
-104.2% ▼
EPS (Diluted)
$-22.19
+20.6% ▲
EBITDA
-$32M
-146.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $871K | $2M | $3M |
| Gross Profit | $0 | $0 | -$871K | -$2M | -$3M |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $23M | $16M | $19M | $25M | $21M |
| SG&A Expenses | $11M | $9M | $8M | $12M | $10M |
| Operating Expenses | $35M | $27M | $27M | $37M | $31M |
| Operating Income | -$35M | -$27M | -$28M | -$39M | -$33M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $699K | $2M | $2M | $3M | $984K |
| Income Before Tax | -$36M | -$28M | -$26M | -$18M | -$36M |
| Tax Expense | $67K | $65K | $23K | $13K | $7K |
| Net Income | -$36M | -$28M | -$26M | -$18M | -$36M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-264.67 | $-180.31 | $-96.90 | $-27.93 | $-22.19 |
| EBITDA | -$33M | -$24M | -$23M | -$13M | -$32M |
| Shares Outstanding | 1M | 2M | 3M | 691M | 1.63B |